Cargando…
Antiviral Immunoglobulins of Chicken Egg Yolk for Potential Prevention of SARS-CoV-2 Infection
Background: Some viruses cause outbreaks, which require immediate attention. Neutralizing antibodies could be developed for viral outbreak management. However, the development of monoclonal antibodies is often long, laborious, and unprofitable. Here, we report the development of chicken polyclonal n...
Autores principales: | Ravlo, Erlend, Evensen, Lasse, Sanson, Gorm, Hildonen, Siri, Ianevski, Aleksandr, Skjervold, Per Olav, Ji, Ping, Wang, Wei, Kaarbø, Mari, Kaynova, Gerda Dominyka, Kainov, Denis E., Bjørås, Magnar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609661/ https://www.ncbi.nlm.nih.gov/pubmed/36298676 http://dx.doi.org/10.3390/v14102121 |
Ejemplares similares
-
Mono- and combinational drug therapies for global viral pandemic preparedness
por: Ianevski, Aleksandr, et al.
Publicado: (2022) -
Active Components of Commonly Prescribed Medicines Affect Influenza A Virus–Host Cell Interaction: A Pilot Study
por: Ianevski, Aleksandr, et al.
Publicado: (2021) -
DrugVirus.info 2.0: an integrative data portal for broad-spectrum antivirals (BSA) and BSA-containing drug combinations (BCCs)
por: Ianevski, Aleksandr, et al.
Publicado: (2022) -
Screening of FDA-Approved Drugs Using a MERS-CoV Clinical Isolate from South Korea Identifies Potential Therapeutic Options for COVID-19
por: Ko, Meehyun, et al.
Publicado: (2021) -
Seven classes of antiviral agents
por: Ianevski, Aleksandr, et al.
Publicado: (2022)